ACCENTIA BIOPHARMACEUTICALS INC

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2007–2013

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2013	—	1	1
2012	—	4	1
2011	—	4	1
2010	—	4	1
2009	—	4	1
2008	—	4	1
2007	—	3	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
AMERICAN DEFENSE INTERNATIONAL INC	—	24

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	14
SENATE	11

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Defense	Defense	16

Bills Explicitly Cited (1)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 2647110th Congress

Mental Health and Substance Abuse Juvenile Services Improvement Act of 2007

2010 · first_quarter · Firm: AMERICAN DEFENSE INTERNATIONAL INC

Open original LDA filing ↗

Cited source text and reported amounts

Department of Defense Appropriations Bill, provisions relating to cancer immunotherapy research. National Defense Authorization Act (HR2647), provisions relating to cancer immunotherapy research.

Client expense: — · Firm income: $20,000

Matched citations: HR2647

Source: Senate LDA

ACCENTIA BIOPHARMACEUTICALS INC — Lobbying Disclosure | Poliscope